CST3 and stroke disorder: Mechanistically, cystatin C contributes to atherosclerosis by disrupting the balance between vascular proteases and antiproteases (e.g., inhibiting cysteine cathepsin activity), promoting plaque formation and instability, thereby increasing stroke risk [17,34].